US FDA extends review of Merus' gene-targeting cancer therapy
The U.S. Food and Drug Administration on Tuesday extended the review of Merus NV's gene-targeting cancer therapy to allow ...
Neuroscience News1d
Could Targeting Genetics Reduce Our Cravings for Sugary Foods?
A new study has revealed how genetic variations in the SI gene, which affects sucrose digestion, influence dietary ...
Baylor College of Medicine4y
Gene Targeting in Mouse ES Cells and Chimera Production–129 and C57BL/6NES cells
The investigator will submit a request form through iLab with a detailed gene targeting strategy and proven screening protocol. An account and IACUC number must be provided at this time. The ES cell ...
Nature1y
Vagaries of conditional gene targeting
Conditional gene targeting based on excision or inversion of loxP-flanked DNA segments by Cre recombinase is a powerful technology for the analysis of gene function, but unexpected expression ...
Gene-edited tomatoes achieve increased sweetness without loss of size or yield
I n a groundbreaking study published in the journal Nature, researchers have successfully used gene editing to create sweeter ...
News Medical on MSN2h
Scientists map cancer mutations in EGFR gene, revealing drug resistance paths
Researchers used base and prime editing to uncover new EGFR gene mutations that affect cancer progression and drug resistance ...
Not a fan of sweets? Scientists link reduced sugar cravings to a gene defect
"If you don’t like sweet foods, it is possible that you have reduced SI function, but it is more likely that other factors ...
Gene therapy protects against motor neuron disease in rats
University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...
Cibus Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in Canola
Cibus has successfully made the edits in Canola associated with the Company’s 4th mode of action for its White Mold (Sclerotinia) trait Builds ...
POSTECH team pioneers new cancer therapy strategy: targeting GLUT3 in regulatory T cells to supercharge anti-tumor immunity
TIL-Tregs specifically increase GLUT3 expression for glucose uptake in tumors. - GLUT3 fuels protein O-GlcNAcylation, ...
technologynetworks1d
Gene Therapy Protects Rats From Motor Neuron Disease
UW–Madison researchers used gene therapy to prevent hereditary spastic paraplegia (HSP) in a rat model, introducing a healthy ...